For Jennifer Gowans, a patient ambassador for the American Kidney Fund, helping others is her go-to coping strategy for life with type 2 diabetes and chronic kidney disease. Chronic kidney disease ...

Chronic kidney disease (CKD) is a progressive condition in which the kidneys are damaged and can’t filter blood effectively. This can eventually lead to a buildup of waste and fluid in the body. In ...

Source: Getty Images Addressing anemia in CKD requires a proactive, multifaceted approach, incorporating both conventional and nutritional strategies. Early recognition and intervention are essential ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...

A new guideline from the Kidney Disease: Improving Global Outcomes (KDIGO) group provides updated recommendations on the management of anemia in chronic kidney disease (CKD), reflecting substantial ...

Finerenone significantly improves eGFR slope in patients with nondiabetic chronic kidney disease, suggesting a slowed progression of renal decline. Topline results were announced from a phase 3 trial ...

SGLT2 inhibitors significantly improve hemoglobin and hematocrit levels in CKD patients, enhancing anemia management. The KDIGO 2024 guideline endorses SGLT2 inhibitors for CKD patients, highlighting ...

Approximately 35 million US adults suffer from chronic kidney disease (CKD), including more than 808,000 with end-stage renal disease (ESRD). Among these patients, an estimated 50%-100% experience at ...

Source: Getty Images As GLP-1 RA use expands in nephrology, gaps in care become more consequential and need to be filled. GLP-1 RAs are most effective as a tool, not a stand-alone solution. Without ...

CKD prevalence has more than doubled since 1990, with 788 million adults affected in 2023, highlighting a significant global health challenge. The disease is a major contributor to cardiovascular ...